Securities Class Action

Securities fraud litigation history and active cases

In Litigation

0

Settlement

0

Closed

1

Total Settlement

$0

Verve Therapeutics, Inc. (VERV) Class Action Lawsuit (August 2024)

Closed

1:24cv12218 • August 27, 2024

Class Period Start

August 9, 2022

Class Period End

April 1, 2024

PSLRA Deadline

October 28, 2024

Case Allegations

10b5

Statutes of Repose

Aug 9, 2025

Country

United States

Court

Federal Court

Docket History

Feb 4, 2025

Voluntary Dismissal (opens in a new tab)

The plaintiff in this action has chosen not to proceed with the case. Once a case is voluntary dismissed, the courts will usually close the case and no further action will be taken.

Dec 6, 2024

Appointment of Lead Plaintiff (opens in a new tab)

The court has appointed a lead plaintiff to represent the interests of investors in the lawsuit. The lead plaintiff works with the attorneys handling the case, helps oversee the litigation, and represents the interests of the proposed class.

Aug 27, 2024

First Filed Complaint (opens in a new tab)

A securities fraud class action complaint has been filed on behalf of certain investors in Verve Therapeutics, Inc..